Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 3 2Phase 1/2 1

Status

Recruiting 9Active not recruiting 3Not yet recruiting 2Terminated 1

Sponsor Class

INDUSTRY 7OTHER 2

Study Type

Interventional 8Observational 1

Sponsor

Cancer Type

Breast 9

Conditions

Breast Neoplasms 9Neoplasms 1Neoplasm, Residual 1Neoplasm Metastasis 1Metastatic Castration-Resistant Prostate Cancer 1HER2-positive Breast Cancer 1Endometrial Neoplasms 1Colorectal Neoplasms 1

Interventions

Fulvestrant 60Capecitabine 47Trastuzumab 46Letrozole 45pembrolizumab 42Carboplatin 41Paclitaxel 39Cyclophosphamide 38ribociclib 37abemaciclib 36pertuzumab 34Blood Specimen Collection 31Specimen Handling 28trastuzumab deruxtecan 27Surveys and Questionnaires 26Docetaxel 26Tamoxifen 25Anastrozole 25exemestane 24palbociclib 21130-nm albumin-bound paclitaxel 21Magnetic Resonance Spectroscopy 20Biopsy 19sacituzumab govitecan 18eribulin 18Radiotherapy 18Gemcitabine 18olaparib 17Injections 17Epirubicin 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

9 trials
RecentStart dateEnrollment
Recruiting × Breast Neoplasms × inavolisib × Clear all
NCT07054190 2026-05-26

A Study to Test Inavolisib Treatments in Participants With Early-Stage, PIK3CA-Mutated Breast Cancer

Hoffmann-La Roche

Phase 2 Recruiting
60 enrolled
Breast

Breast Neoplasms

NCT07347600 2026-05-18

reaINAVO

Hoffmann-La Roche

Recruiting
500 enrolled
Breast

Breast Neoplasms

NCT07405801 2026-05-18

A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer

Hoffmann-La Roche

Phase 2 Recruiting
80 enrolled
Breast

Breast Neoplasms

NCT07368998 2026-05-11

optINAVO

Hoffmann-La Roche

Phase 2 Recruiting
80 enrolled
Breast

Breast Neoplasms

NCT06790693 2026-05-04

INAVO123

Hoffmann-La Roche

Phase 3 Recruiting
450 enrolled
Breast

Breast Neoplasms

NCT05894239 2026-05-01

INAVO122

Hoffmann-La Roche

Phase 3 Recruiting
230 enrolled
Breast

Breast Neoplasms

NCT03424005 2026-03-16

Morpheus-panBC

Hoffmann-La Roche

Phase 1/2 Recruiting
792 enrolled
Breast

Breast Neoplasms

NCT05708235 2026-03-05

MiRaDoR

MedSIR

Phase 2 Recruiting
976 enrolled
Breast

Breast Neoplasms, Neoplasm, Residual

NCT05332561 2025-03-20

Genomics Guided Targeted Post-neoadjuvant Therapy in Patients With Early Breast Cancer (COGNITION-GUIDE)

German Cancer Research Center

Phase 2 Recruiting
240 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡